Colombia vs Tajikistan: Cause of death, by non-communicable diseases, male
Colombia
50.7%
in 2021
Tajikistan
51.2%
in 2021
Colombia rank
114th
Tajikistan rank
112th
Cause of death, by non-communicable diseases, male over time
- Colombia
- Tajikistan
How they compare
Tajikistan currently reports 51.2% against 50.7% in Colombia, a difference of 0.5%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Tajikistan ahead.
Colombia ranks 114th and Tajikistan ranks 112th of 185 countries.
Across the 3 decades both report, Colombia averaged higher in 2 and Tajikistan in 1.
Head to head by decade
| Decade | Colombia | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 47.5% | 48.9% | 1.4% | Tajikistan |
| 2010s | 63.9% | 60.4% | 3.6% | Colombia |
| 2020s | 53.6% | 50.1% | 3.5% | Colombia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, male, Colombia or Tajikistan?
- Tajikistan, at 51.2% against 50.7% in Colombia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, male between Colombia and Tajikistan?
- 0.5%, with Tajikistan ahead.
- How many years of comparable data are there for Colombia and Tajikistan?
- 6 years are reported by both, from 2000 to 2021.
- How do Colombia and Tajikistan rank globally for cause of death, by non-communicable diseases, male?
- Colombia ranks 114th and Tajikistan ranks 112th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.